|
Article Excerpt
CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the third quarter of 2005 on Wednesday, November 9, 2005, after the U.S. financial markets close.
Management will provide an update on the company, discuss third quarter results and discuss expectations for the future via conference call on Wednesday, November 9, 2005, at 4:30 pm EST. To access the call, please dial 866-272-9941 (domestic) or 617-213-8895 (international)...
|
|
More articles from Business Wire
Diamant Art Corporation Bulletin: PVC Film can be Detrimental to Human..., November 03, 2005
Fairchild Semiconductor Expands Board of Directors., November 03, 2005
Nektar Announces Third Quarter 2005 Financial Results., November 03, 2005
Ace Reports Results of Its Third Quarter and Nine Months Ended Septemb..., November 03, 2005
Insmed Incorporated Reports Financial Results for the Third Quarter an..., November 03, 2005
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
